Oral agents for acute severe hypertension in children with minimal or no symptoms

Area of Science:

• Pediatric Nephrology
• Cardiology
• Clinical Pharmacology

Background:

• Acute hypertension is a frequent complication in hospitalized children.
• Rapid blood pressure increases pose risks, including posterior reversible encephalopathy syndrome.
• Current guidelines define and recommend management for hypertensive crisis in pediatric patients.

Purpose of the Study:

• To review current guidelines for identifying and managing acute severe hypertension in children.
• To discuss the appropriate use of oral antihypertensive agents for asymptomatic or minimally symptomatic pediatric patients.
• To compare pharmacokinetic and pharmacodynamic properties of oral antihypertensive agents, focusing on calcium channel blockers like isradipine.

Main Methods:

• Literature review of current international guidelines (US and Europe).
• Analysis of oral antihypertensive agents, with a focus on calcium channel blockers.
• Comparison of pharmacokinetic and pharmacodynamic profiles of selected agents.

Main Results:

• Guidelines provide definitions for hypertensive crisis and management strategies.
• Oral antihypertensive agents are suitable for select pediatric cases.
• Isradipine, a second-generation dihydropyridine, is highlighted due to recent regulatory changes.

Conclusions:

• Effective management of pediatric hypertensive crisis relies on guideline adherence.
• Understanding drug properties is crucial for selecting and dosing oral antihypertensives in children.
• Calcium channel blockers, including isradipine, represent a viable option for specific pediatric hypertension scenarios.